KRISTEL HOWELL: Open Payments
NPI 1326344789 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,302 in 13 payments from 10 companies in 2025. Trend: 2023 $685 · 2024 $1,233 · 2025 $1,302
Food & beverage: $1,302
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $324 |
| Deciphera Pharmaceuticals Inc. | 1 | $161 |
| Genentech, Inc. | 2 | $122 |
| E.R. Squibb & Sons, L.L.C. | 1 | $111 |
| Janssen Biotech, Inc. | 1 | $109 |
| AstraZeneca Pharmaceuticals LP | 1 | $109 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $107 |
| PFIZER INC. | 1 | $98 |
| Gilead Sciences, Inc. | 1 | $97 |
| Regeneron Healthcare Solutions, Inc. | 1 | $65 |
Products named: QINLOCK, EPKINLY, VENCLEXTA, Itovebi, OPDIVO, RYBREVANT, DATROWAY, Nubeqa.
Industry payments across IA — which companies pay providers there.
